The Australian Academy of Science has announced $190,000 to help the survival of some of Australia's endangered species, help prevent hospital readmissions in central Australia, model climate change adaptation and support international travel and scientific conferences. [ + ]

Merck's healthcare business has entered into a three-year collaboration to validate new therapeutic concepts in the field of oncology with drug discovery company Selvita, headquartered in Poland. [ + ]

University of Sydney researchers have identified and mapped the genetic traits that will improve the accuracy of breeding high-performing working dogs for Australian farmers. [ + ]

Physicists have discovered a phase that is characterised by an unusual ordering of electrons. It is said that the phase could hold the solution to a longstanding mystery in condensed matter physics. [ + ]

Researchers have identified the key protein involved in driving the progression of multiple sclerosis (MS) and other autoimmune diseases through the body's 'super-inflammatory' immune response. [ + ]

Senator Simon Birmingham has confirmed funding for 889 new research projects as part of the Australian Research Council's (ARC) Major Grants announcement. [ + ]

Chemists have created a star-shape molecule, previously thought to be too unstable to be made, in work which could lead to more efficient ways to make medicinal agents.

Scientists have discovered a potential new treatment for tuberculosis — a disease whose resistance to current medical therapies has enabled it to infect 30% of the globe's population.

Researchers have discovered that the humble guppy may be smarter than other fish, with strongly lateralised brains that give them the ability to count. [ + ]

Regeneus has announced that the first patient has been enrolled and treated in a clinical trial of the company's autologous tumour vaccine, RGSH4K. [ + ]

Scientists from The University of Queensland have discovered two new microorganisms which are said to play an unknown role in greenhouse gas emissions and consumption. [ + ]

Prime Minister Malcolm Turnbull has announced that Dr Alan Finkel AO will be Australia's next Chief Scientist. [ + ]

TGR BioSciences has announced a European licence agreement with Prime Diagnostics — a developer of high-quality diagnostics, technologies and services for the agricultural sector. [ + ]

Minomic International will next year launch a human study of its monoclonal antibody technology as an imaging agent to detect prostate, pancreatic and bladder cancers. [ + ]

Medlab Clinical has been granted ethics approval to begin two separate human trials using its nanotechnology delivery platform, NanoCelle. The platform, previously developed for cannabis research, converts pharmaceuticals into nanoparticle form. [ + ]